KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Total Debt (2019 - 2025)

Historic Total Debt for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Q3 2025 value amounting to $59.7 million.

  • Rigel Pharmaceuticals' Total Debt fell 5.35% to $59.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.7 million, marking a year-over-year decrease of 5.35%. This contributed to the annual value of $59.7 million for FY2024, which is 13.09% up from last year.
  • Rigel Pharmaceuticals' Total Debt amounted to $59.7 million in Q3 2025, which was down 5.35% from $59.8 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Total Debt high stood at $59.8 million for Q2 2025, and its period low was $19.8 million during Q1 2021.
  • In the last 5 years, Rigel Pharmaceuticals' Total Debt had a median value of $59.6 million in 2023 and averaged $46.0 million.
  • In the last 5 years, Rigel Pharmaceuticals' Total Debt surged by 10189.24% in 2021 and then decreased by 5.35% in 2025.
  • Rigel Pharmaceuticals' Total Debt (Quarter) stood at $19.9 million in 2021, then skyrocketed by 98.09% to $39.4 million in 2022, then surged by 51.09% to $59.6 million in 2023, then grew by 0.13% to $59.7 million in 2024, then grew by 0.08% to $59.7 million in 2025.
  • Its Total Debt stands at $59.7 million for Q3 2025, versus $59.8 million for Q2 2025 and $59.7 million for Q1 2025.